# Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

> **NCT01825512** · PHASE3 · COMPLETED · sponsor: **Consorzio per Valutazioni Biologiche e Farmacologiche** · enrollment: 435 (actual)

## Conditions studied

- Chronic Iron Overload

## Interventions

- **DRUG:** Deferiprone
- **DRUG:** Deferasirox

## Key facts

- **NCT ID:** NCT01825512
- **Lead sponsor:** Consorzio per Valutazioni Biologiche e Farmacologiche
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-17
- **Primary completion:** 2017-09-21
- **Final completion:** 2017-09-21
- **Target enrollment:** 435 (ACTUAL)
- **Last updated:** 2021-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825512, "Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01825512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*